Cl-Amidine (trifluoroacetate salt): PAD4 Deimination Activity Inhibitor for Advanced Research

Executive Summary: Cl-Amidine (trifluoroacetate salt) is a highly selective inhibitor of protein arginine deiminase 4 (PAD4), a key enzyme involved in histone citrullination and epigenetic regulation (Telerman et al., 2022). Its efficacy has been demonstrated in both in vitro and in vivo models, including significant suppression of neutrophil extracellular trap (NET) formation and improved survival in septic shock murine models (Telerman et al., 2022). Cl-Amidine outperforms related inhibitors such as F-amidine, displaying superior potency and selectivity [internal review]. The compound is provided as a crystalline solid (molecular weight 424.8) by APExBIO and is validated for reproducibility and solubility in DMSO and water (APExBIO product page). It is indicated for research use only, with specific storage and handling parameters.

Biological Rationale

Protein arginine deiminase 4 (PAD4) catalyzes the post-translational conversion of arginine residues to citrulline on histones and other nuclear proteins. This process, termed citrullination or deimination, alters chromatin structure and regulates gene expression (Telerman et al., 2022). Dysregulated PAD4 activity has been implicated in the pathogenesis of cancer, autoimmune diseases such as rheumatoid arthritis, and inflammatory conditions. Elevated PAD4 and histone H3 citrullination are linked to increased neutrophil extracellular trap (NET) formation in chronic myeloid leukemia and other disorders (Telerman et al., 2022). Targeting PAD4 thus provides a mechanistic entry point for dissecting epigenetic, immune, and inflammatory pathways.

Mechanism of Action of Cl-Amidine (trifluoroacetate salt)

Cl-Amidine (trifluoroacetate salt) is a haloacetamidine-based small molecule that irreversibly inhibits PAD4 by covalently modifying the enzyme's active site cysteine. This selective inhibition blocks the deimination of arginine residues, preventing the formation of citrullinated histones and downstream chromatin decondensation (see mechanistic review). In cell-based assays, Cl-Amidine impedes PAD4-mediated NET formation and reduces histone H3 citrullination levels. Compared to F-amidine, Cl-Amidine demonstrates higher potency and selectivity for PAD4, with minimal off-target effects on other PAD isoforms under standard assay conditions (internal benchmarking). The trifluoroacetate salt form ensures enhanced stability and solubility for research workflows.

Evidence & Benchmarks

• Cl-Amidine (trifluoroacetate salt) inhibits PAD4 enzymatic activity in vitro at nanomolar to micromolar concentrations, as measured by histone citrullination assays (Telerman et al., 2022, DOI).
• In BCR-ABL1-transduced HoxB8 mouse neutrophil models, Cl-Amidine significantly suppresses NET formation, as evidenced by decreased H3cit and myeloperoxidase (MPO) expression (Telerman et al., 2022, DOI).
• Cl-Amidine improves survival and immune cell recovery in murine cecal ligation and puncture (CLP) models of septic shock by reducing bone marrow and thymic atrophy and attenuating pro-inflammatory cytokine production (internal review).
• The compound displays high solubility (≥20.55 mg/mL in DMSO; ≥9.53 mg/mL in water with ultrasonication) and is stable for short-term storage at -20°C (APExBIO product page).
• Cl-Amidine exhibits negligible inhibition of NADPH-dependent NETosis, confirming mechanistic selectivity for the PAD4-dependent pathway (Telerman et al., 2022, DOI).

This article extends 'Precision Targeting of PAD4: Cl-Amidine Trifluoroacetate...' by providing updated quantitative evidence for in vivo efficacy and workflow parameters in immune disease models. It clarifies the selectivity profile compared to 'Harnessing PAD4 Inhibition for Advanced Translational Res...' with direct reference to recent peer-reviewed studies.

Applications, Limits & Misconceptions

Cl-Amidine (trifluoroacetate salt) is validated for use in:

• PAD4 enzyme activity assays (colorimetric, fluorometric, and immunodetection platforms)
• Cell-based studies of histone citrullination and chromatin regulation
• Pre-clinical models of inflammatory disease, cancer, and septic shock
• Dissecting the protein arginine deimination pathway in translational research

Common Pitfalls or Misconceptions

• Cl-Amidine is not suitable for diagnostic or therapeutic use in humans; it is for laboratory research only (APExBIO).
• The compound does not inhibit NET formation via NADPH oxidase-dependent (ROS-mediated) pathways (Telerman et al., 2022, DOI).
• Long-term storage of stock solutions leads to loss of activity; fresh preparations are recommended for each experiment (lab workflow guide).
• Cl-Amidine is insoluble in ethanol and should not be used with ethanol-based solvents (APExBIO).
• PAD4 selectivity may vary at supraphysiological concentrations; careful titration is required for isoform-specific studies.

Workflow Integration & Parameters

For optimal results, Cl-Amidine (trifluoroacetate salt) (SKU C3829) should be dissolved at concentrations up to 20.55 mg/mL in DMSO or 9.53 mg/mL in water (with ultrasonic assistance) immediately before use. Storage at -20°C is recommended for the solid form, with aliquoting to minimize freeze-thaw cycles. For PAD4 enzyme assays, typical working concentrations range from 0.1 to 100 μM, depending on the assay format and cell type. In cell-based NETosis or citrullination assays, pre-incubation for 30–60 minutes at 37°C is standard. The use of Cl-Amidine in animal models should be guided by peer-reviewed protocols, with dosing regimens tailored to the specific disease context. APExBIO supplies validated product documentation and certificates of analysis for batch reproducibility (APExBIO product page).

Conclusion & Outlook

Cl-Amidine (trifluoroacetate salt) has established itself as a gold-standard PAD4 deimination activity inhibitor for mechanistic and translational research. Its high selectivity, reproducibility, and proven efficacy in disease models make it an indispensable tool for interrogating the protein arginine deimination pathway and developing epigenetic and immunomodulatory strategies. As the landscape of PAD4 research evolves, standardized reagents from APExBIO ensure consistent results and facilitate cross-study comparisons. Future work will further elucidate PAD4's role in disease and expand Cl-Amidine's utility in advanced model systems.